Search results

  1. forestglip

    United Kingdom: ME Research UK (MERUK) News

    ME Research UK – June e-newsletter [Links to S4ME threads added in brackets] Promising Findings from Our Researchers Articles London Marathon Place Big Give Christmas Challenge – Pledge Today Walk for ME – Thank you Alison! Link
  2. forestglip

    Unevidenced recommendations of brain retraining in Bateman Horne Centers clinical guide for ME and longcovid

    Doesn't this apply to basically all potential drug treatments as well? Separately, I'm pretty certain the second response from them is mostly written by an AI. The gratuitous bolding for emphasis, the section headers for each point, the summary at the end, the use of em dashes, and some of the...
  3. forestglip

    PEM-like descriptions and accounts in non-ME illnesses

    Well, I'm exhausted, and I'm not totally sure we're even discussing the same thing, so I'm going to call it for now.
  4. forestglip

    PEM-like descriptions and accounts in non-ME illnesses

    Similar for me. Sometimes delayed, sometimes seems pretty immediate.
  5. forestglip

    PEM-like descriptions and accounts in non-ME illnesses

    Well, it wouldn't really fit the name of "malaise", so if only for that reason, it wouldn't seem to fit. But for the reasons I said, I think that is kind of arbitrary. Just saying that if fatigue+brain fog+vomiting is considered PEM, then vomiting is considered connected to the PEM process...
  6. forestglip

    PEM-like descriptions and accounts in non-ME illnesses

    Hmm, yeah I suppose. I think my mental model of PEM is a delay plus it lasting strangely long (greater than 2 or 3 days) plus it being quite out of proportion to the exertion.
  7. forestglip

    PEM-like descriptions and accounts in non-ME illnesses

    Is that the case? With muscle soreness, there's the DOMS diagnosis, right? But, people often suddenly get a lot more fatigued a day later? Maybe I'm working with an incorrect assumption that that is pretty rare.
  8. forestglip

    PEM-like descriptions and accounts in non-ME illnesses

    I just think its arbitrary to use 3 symptoms instead of 1. I think we should err on the side of being potentially over-inclusive, not over-exclusive, for the sake of patients who, without the established ME/CFS communities [edit: like this forum] and support systems, [edit: and without any other...
  9. forestglip

    PEM-like descriptions and accounts in non-ME illnesses

    No, I understood. I'm saying if we accept that vomiting is part of the pathophysiological PEM process if it occurs alongside fatigue, it seems logical to assume it could be related on its own as well. I'm mainly considering a delay of a single symptom if it's already associated with PEM if...
  10. forestglip

    PEM-like descriptions and accounts in non-ME illnesses

    Maybe. So in that case, delayed fatigue, brain fog, and unrefreshing sleep are the three things required for it to be PEM? If someone had worsening fatigue, brainfog, and vomiting after 24 hours consistently, and the vomiting was considered related to PEM and not some total coincidence, then I...
  11. forestglip

    PEM-like descriptions and accounts in non-ME illnesses

    I added the "not explained by anything else", but otherwise that basically seems like the NICE definition. They don't specify any specific symptoms in this definition. Why not? I think the most potentially useful way to separate PEM from pretty much anything else is that following a delay after...
  12. forestglip

    PEM-like descriptions and accounts in non-ME illnesses

    If someone exercises and consistently 24 hours later they suddenly get a lot more fatigued, what is it if not PEM? Is there an established condition that this fits with? If not, what's the purpose of excluding those people and leaving them with no diagnosis? PEM is just describing a pattern that...
  13. forestglip

    PEM-like descriptions and accounts in non-ME illnesses

    How could the fatigue be both rapid onset and delayed?
  14. forestglip

    Review Interventions for the management of long covid post-covid condition: living systematic review, 2024, Zeraatkar, Flottorp, Garner, Busse+

    It seems like there are three possible options: 1. Point estimate over MID, compare CI to null - evidence of any effect 2. Point estimate over MID, compare CI to MID - evidence of important effect 3. Point estimate below MID, compare CI to MID - evidence against an important effect? And I think...
  15. forestglip

    Review Interventions for the management of long covid post-covid condition: living systematic review, 2024, Zeraatkar, Flottorp, Garner, Busse+

    I see, thanks. Do you mean no important effect? We see that there's likely a nonzero effect since the CI doesn't cross null. And that's how they worded the plain language summary for vortioxetine. My brain is swimming trying to fully grasp it, but it seems weird to compare evidence for no...
  16. forestglip

    Review Interventions for the management of long covid post-covid condition: living systematic review, 2024, Zeraatkar, Flottorp, Garner, Busse+

    I'm trying to understand this. So if, say, the MID is 1, and a study A has a result of 1.1, CI: 0.9-1.3 (same shape as b in fig. 5 above), then because the point estimate exceeds the MID, they downgrade for imprecision because the CI goes below the MID. But if a study B result is 0.8, CI...
  17. forestglip

    Review Deep brain stimulation for obsessive-compulsive-disorder: a systematic review and meta-analysis [...], 2025, Cohen et al

    Deep brain stimulation for obsessive-compulsive-disorder: a systematic review and meta-analysis of individual participant outcome data from sham-controlled trials Sem E. Cohen, Marisa J. Niemeijer, Jasper B. Zantvoord, Guido A. van Wingen, Roel J. T. Mocking & Damiaan Denys S [Line breaks...
  18. forestglip

    Oxaloacetate

    New study on long COVID: S4ME thread: REGAIN: A Randomized Controlled Clinical Trial of Oxaloacetate for Improving the Symptoms of Long COVID, 2025, Vernon et al
  19. forestglip

    Trial Report REGAIN: A Randomized Controlled Clinical Trial of Oxaloacetate for Improving the Symptoms of Long COVID, 2025, Vernon et al

    REGAIN: A Randomized Controlled Clinical Trial of Oxaloacetate for Improving the Symptoms of Long COVID Suzanne D Vernon, Candace Rond, Jennifer Bell, Brindisi Butler, Sara Isolampi, Annaleah Otteson, Pearl Phalwane, Samantha Mower, Shad Roundy, David Kaufman, Alan Brian Cash, Lucinda Bateman...
Back
Top Bottom